The varicose vein wall remodeling is a very complex process, which is controlled by numerous factors, including peptide growth factors. The aim of the study was to assess a/b FGF, IGF-1, TGF-β1, VEGF-A and their receptors in the vein wall. Varicose vein samples were taken from 24 patients undergoing varicose vein surgery. The control material consisted of vein specimens collected from 12 patients with chronic limb ischemia. Contents of aFGF, bFGF, IGF-I, TGF-β1, VEGF, IGF-1R, VEGF R1 and VEGF R2 were assessed with ELISA method. Protein expression of FGF R1 and TGF-β RII were evaluated with western blot. Increased contents of aFGF, IGF-1 and VEGF-A were found in varicose veins in comparison with normal ones (p<0.05). In contrast, a significant decrease in TGF-β content was demonstrated in varicose veins (p<0.05). Furthermore, there was no difference in bFGF content in both groups (p>0.05). IGF-1 R content was significantly increased in varicose veins (p<0.05). There was no difference in VEGF R1 content between varicose and normal veins (p>0.05), whereas VEGF R2 content was significantly increased in varicose veins (p<0.05). Western blot demonstrated increased expression of TGF-β RII in varicose veins (p<0.05) and similar expression of FGF R1 in both groups (p>0.05). Demonstrated changes in peptide growth factors and their receptors may disturb metabolism of extracellular matrix in the varicose vein wall and contribute to the development of the disease to its more advanced stages.
SegietOA, Brzozowa-ZasadaM, PiecuchA, . Biomolecular mechanisms in varicose veins development. Ann Vasc Surg2015;29:377–84.doi:10.1016/j.avsg.2014.10.009
3.
Sansilvestri-MorelP, RupinA, Badier-CommanderC, . Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res2001;38:560–8.doi:10.1159/000051092
4.
WolańskaM, SobolewskiK, GlowińskiS, . Glycosaminoglycans of normal veins and their alterations in varicose veins and varicose veins complicated by thrombophlebitis. Eur Surg Res2001;33:28–32.doi:10.1159/000049689
5.
BirdinaJ, PilmaneM, LigersA. The morphofunctional changes in the wall of varicose veins. Ann Vasc Surg2017;42:274–84.doi:10.1016/j.avsg.2016.10.064
6.
DemirkıranMA, KöksoyC, HeperAO, . Does extracellular matrix of the varicose vein wall change according to clinical stage?Ulus Cerrahi Derg2014;30:186–91.doi:10.5152/UCD.2014.2664
7.
GörmüsU, Timirci-KahramanO, ErgenA, . Expression levels of elastin and related genes in human varicose veins. Folia Biol2014;60:68–73.
8.
Barallobre-BarreiroJ, OkluR, LynchM, . Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins. Cardiovasc Res2016;110:419–30.doi:10.1093/cvr/cvw075
9.
SerralheiroP, SoaresA, Costa AlmeidaCM, . TGF-β1 in vascular wall pathology: unraveling chronic venous insufficiency pathophysiology. Int J Mol Sci2017;26:1–20.
10.
NummenmaaE, HämäläinenM, MoilanenT, . Effects of FGF-2 and FGF receptor antagonists on MMP enzymes, aggrecan, and type II collagen in primary human OA chondrocytes. Scand J Rheumatol2015;44:321–30.doi:10.3109/03009742.2014.1000372
11.
BassolsA, MassaguéJ. Transforming growth factor beta regulates the expression and structure of extracellular matrix chondroitin/dermatan sulfate proteoglycans. J Biol Chem1988;263:3039–45.
12.
Eghbali-FatourechiG, SieckGC, PrakashYS, . Type I procollagen production and cell proliferation is mediated by transforming growth factor-beta in a model of hepatic fibrosis. Endocrinology1996;137:1894–903.doi:10.1210/endo.137.5.8612529
13.
WangH, KeiserJA. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1. Circ Res1998;83:832–40.doi:10.1161/01.RES.83.8.832
14.
KowalewskiR, MalkowskiA, SobolewskiK, . Evaluation of aFGF/bFGF and FGF signaling pathway in the wall of varicose veins. J Surg Res2009;155:165–72.doi:10.1016/j.jss.2008.07.032
15.
Badier-CommanderC, CouvelardA, HeninD, . Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol2001;193:398–407.doi:10.1002/path.819
16.
PascualG, MendietaC, García-HonduvillaN, . TGF-beta1 upregulation in the aging varicose vein. J Vasc Res2007;44:192–201.doi:10.1159/000100375
17.
KowalewskiR, MalkowskiA, GackoM, . Influence of thrombophlebitis on TGF-β1 and its signaling pathway in the vein wall. Folia Histochem Cytobiol2010;48:542–8.doi:10.2478/v10042-010-0041-z
18.
HollingsworthSJ, PowellG, BarkerSG, . Primary varicose veins: altered transcription of VEGF and its receptors (KDR, flt-1, soluble flt-1) with sapheno-femoral junction incompetence. Eur J Vasc Endovasc Surg2004;27:259–68.doi:10.1016/j.ejvs.2003.12.015
19.
ShoabSS, ScurrJH, Coleridge-SmithPD. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg1998;28:535–40.doi:10.1016/S0741-5214(98)70141-7
20.
AraújoFA, RochaMA, MendesJB, . Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. Biomed Pharmacother2010;64:29–34.doi:10.1016/j.biopha.2009.03.003
21.
BradfordMM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem1976;72:248–54.doi:10.1016/0003-2697(76)90527-3
22.
LimCS, GohelMS, ShepherdAC, . Venous hypoxia: a poorly studied etiological factor of varicose veins. J Vasc Res2011;48:185–94.doi:10.1159/000320624
23.
StrniskováM, RavingerováT, NeckárJ, . Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia. Gen Physiol Biophys2006;25:25–41.
24.
KowalewskiR, SobolewskiK, WolanskaM, . Matrix metalloproteinases in the vein wall. Int Angiol2004;23:164–9.
25.
GomezI, BenyahiaC, LouedecL, . Decreased PGE2 content reduces MMP-1 activity and consequently increases collagen density in human varicose vein. PLoS One2014;9:1–9.doi:10.1371/journal.pone.0088021
26.
KucukguvenA, KhalilRA. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins. Curr Drug Targets2013;14:287–324.
27.
Sansilvestri-MorelP, RupinA, JullienND, . Decreased production of collagen Type III in cultured smooth muscle cells from varicose vein patients is due to a degradation by MMPs: possible implication of MMP-3. J Vasc Res2005;42:388–98.doi:10.1159/000087314
28.
DrubaixI, GiakoumakisA, RobertL, . Preliminary data on the age-dependent decrease in basic fibroblast growth factor and platelet-derived growth factor in the human vein wall and in their influence on cell proliferation. Gerontology1998;44:9–14.doi:10.1159/000021976
29.
HarmerNJ. Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans2006;34:442–5.doi:10.1042/BST0340442
30.
DelafontaineP, SongYH, LiY. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler Thromb Vasc Biol2004;24:435–44.doi:10.1161/01.ATV.0000105902.89459.09
31.
LiM, ChiuJF, GagneJ, . Age-related differences in insulin-like growth factor-1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells. J Cell Physiol2008;217:377–87.doi:10.1002/jcp.21507
32.
SunL, GaoZ, LuoL, . Estrogen affects cell growth and IGF-1 receptor expression in renal cell carcinoma. Onco Targets Ther2018;11:5873–8.doi:10.2147/OTT.S172149
33.
MashiahA, BermanV, TholeHH, . Estrogen and progesterone receptors in normal and varicose saphenous veins. Cardiovasc Surg1999;7:327–31.doi:10.1016/S0967-2109(98)00132-X
McCaffreyTA, FalconeDJ, BraytonCF, . Transforming growth factor-beta activity is potentiated by heparin via dissociation of the transforming growth factor-beta/alpha 2-macroglobulin inactive complex. J Cell Biol1989;109:441–8.doi:10.1083/jcb.109.1.441
36.
ItoT, WilliamsJD, FraserD, . Hyaluronan attenuates transforming growth factor-beta1-mediated signaling in renal proximal tubular epithelial cells. Am J Pathol2004;164:1979–88.doi:10.1016/S0002-9440(10)63758-3
37.
KoehlerL, SamsonovS, RotherS, . Sulfated hyaluronan derivatives modulate TGF-β1: receptor complex formation: possible consequences for TGF-β1 signaling. Sci Rep2017;26:1–11.
38.
VuTT, MarquezJ, LeLT, . The role of decorin in cardiovascular diseases: more than just a decoration. Free Radic Res2018;52:1210–9.doi:10.1080/10715762.2018.1516285
39.
SerralheiroP, NovaisA, CairrãoE, . Variability of MMP/TIMP and TGF-β1 receptors throughout the clinical progression of chronic venous disease. Int J Mol Sci2017;21:1–14.
40.
SerralheiroP, CairrãoE, MaiaCJ, . Effect of TGF-beta1 on MMP/TIMP and TGF-beta1 receptors in great saphenous veins and its significance on chronic venous insufficiency. Phlebology2017;32:334–41.doi:10.1177/0268355516655067
41.
HowladerMH, Coleridge SmithPD. Relationship of plasma vascular endothelial growth factor to CEAP clinical stage and symptoms in patients with chronic venous disease. Eur J Vasc Endovasc Surg2004;27:89–93.doi:10.1016/j.ejvs.2003.10.002
42.
TisatoV, ZauliG, GianesiniS, . Modulation of circulating cytokine-chemokine profile in patients affected by chronic venous insufficiency undergoing surgical hemodynamic correction. J Immunol Res2014;2014:1–10.doi:10.1155/2014/473765
43.
Al-ZoubiNA, YaghanRJ, MazahrehTS, . Evaluation of plasma growth factors (VEGF, PDGF, EGF, ANG1, and ANG2) in patients with varicose veins before and after treatment with endovenous laser ablation. Photomed Laser Surg2018;36:169–73.doi:10.1089/pho.2017.4355
44.
AdylkhanovF, FursovA, NosoY. Determination of vascular endothelial growth factor concentration in serum of patients with varicose veins after conventional phlebectomy and hybrid treatment. Klin Khir2019;85:33–7.doi:10.26779/2522-1396.2019.02.33
45.
FlórezA, De HaroJ, BledaS, . Analysis of vascular endothelial growth factor gene expression in the tissues of patients with chronic venous insufficiency. Phlebology2013;28:32–7.doi:10.1258/phleb.2011.011102
46.
RegaG, KaunC, DemyanetsS, . Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo. Arterioscler Thromb Vasc Biol2007;27:1587–95.doi:10.1161/ATVBAHA.107.143081
47.
SimovartHE, AunapuuM, LiebergJ, . Age-related changes in apoptosis and expressions of intercellular adhesion molecule-1 and vascular endothelial growth factor receptor type 2 in the wall of varicose veins. Int Angiol2010;29:507–13.
